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Abstract
Introduction: Increasing obesity and type 2 diabetes, in part due to the high-fat (HF) Western diet, parallels an
increased incidence of osteoarthritis (OA). This study was undertaken to establish a causal relation between the HF
diet and accelerated OA progression in a mouse model and to determine the relative roles of weight gain and
metabolic dysregulation in this progression.
Methods: Five-week-old C57BL/6 mice were placed on HF (60% kcal) or low-fat (lean, 10% kcal) diets for 8 or 12
weeks before transecting the medial collateral ligament and excising a segment of the medial meniscus of the
knee to initiate OA. One group was switched from lean to HF diet at the time of surgery.
Results: Body weight of mice on the HF diet peaked at 45.9 ± 2.1 g compared with 29.9 ± 1.8 g for lean diets,
with only those on the HF becoming diabetic. Severity of OA was greater in HF mice, evidenced by the
Osteoarthritis Research Society International (OARSI) histopathology initiative scoring method for mice and articular
cartilage thickness and area. To assess the importance of weight gain, short- and long-term HF diets were
compared with the lean diet. Short- and long-term HF groups outweighed lean controls by 6.2 g and 20.5 g,
respectively. Both HF groups became diabetic, and OA progression, evidenced by increased OARSI score, decreased
cartilage thickness, and increased osteophyte diameter, was comparably accelerated relative to those of lean
controls.
Conclusions: These results demonstrate that the HF diet accelerates progression of OA in a type 2 diabetic mouse
model without correlation to weight gain, suggesting that metabolic dysregulation is a comorbid factor in OA-
related cartilage degeneration.
Introduction
Decreased physical activitya n dt h ec o n s u m p t i o no fa
high-fat Western diet have contributed to a worldwide
epidemic of obesity and associated type 2 diabetes [1].
As a result, the incidence of cardiovascular disease,
hypertension, cancer, nonalcoholic fatty liver disease,
stroke, and other secondary complications is anticipated
to be negatively affected [2,3]. One additional conse-
quence of this epidemic is an increased incidence of
osteoarthritis (OA) in both weight-bearing and non-
weight-bearing joints [4,5], with more than 50% of those
with diabetes having some form of arthritis [4]. In the
United States, 52.1% of patients receiving knee replace-
ments in 2005 were obese [6]. In Canada, 87% were
either obese or overweight [7]. A morbidly obese patient
is 33 times more likely to require knee replacement
than is an individual of normal body mass [7]. Despite
these statistics, current knowledge does not adequately
explain the relative contribution to OA of biomechanical
changes resulting from increased body mass versus the
metabolic dysfunction in obesity. Although it is widely
accepted that the increased biomechanical stresses on
the weight-bearing diarthrodial joints due to obesity can
initiate and accelerate the OA disease process [8], the
potential influence of metabolic dysfunction on the pro-
gression of OA is receiving increasing attention [9,10].
Increased dietary fat, as consumed in Western diets,
can contribute to both obesity and the metabolic dys-
function that is associated with insulin resistance/type 2
diabetes. Surplus dietary fat is deposited in adipose tis-
sue as well as in skeletal muscle, heart, and liver. As this
fat burden increases, adverse effects on systemic
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resistance of obesity as a proinflammatory state is based
in part on the observation that adipose tissue in obese
individuals and animal models contains increased num-
bers of activated macrophages that release proinflamma-
tory cytokines such as interleukin-1, interleukin-6, and
tumor necrosis factor-a [12,13]. These cytokines act
both locally on adipocytes and systemically to impair
insulin action in insulin-target tissues [11,14,15]. Meta-
bolism of the abundant circulating free fatty acids in the
high-fat diet can also lead to oxidative stress in cells,
formation of lipid peroxides, and subsequent oxidative
damage to DNA, RNA, and proteins [16-18]. Oxidative
stress has been more specifically shown to inhibit insu-
lin-receptor signaling pathways in cells, at least in part
through activation of the stress kinases JNK and p38
and to impair mitochondrial function [19,20]. The net
effect of the proinflammatory state and tissue oxidative
stress is a systemic metabolic dysfunction that defines
the metabolic syndrome and type 2 diabetes that are
associated with high-fat diets and obesity.
Although it is widely accepted that the increased bio-
mechanical stress associated with obesity contributes to
the initiation/progression of OA [21-23], the importance
of type 2 diabetes-related systemic metabolic dysregula-
tion in the OA disease process has not been delineated.
To begin to address this question, an animal model was
used to test the hypothesis that HF diet-induced obesity
and associated glucose intolerance/insulin resistance
accelerate the progression of osteoarthritis after menis-
c a l / l i g a m e n t o u si n j u r y( M L I ) .T h i sm o d e lw a ss u b s e -
quently used to determine whether marked obesity is
required for the HF diet to accelerate OA.
Materials and methods
Animals
Male C57BL/6J mice purchased from Jackson Labora-
tories (Bar Harbor, ME) were housed five per cage in a
microisolator room on a 12-hour light/dark cycle at the
University of Rochester. Mice were placed on a high-fat
(60% kcal, D12492) or low-fat (10% kcal, D12450B) diet
at 5 weeks of age (Open Source Diets, Research Diets
Inc., New Brunswick, NJ). After 8 or 12 weeks on the
diet, mice were anesthetized by using intraperitoneal
(IP) injection of 60 mg/kg ketamine and 4 mg/kg xyla-
zine, and the medial collateral ligament of the right hin-
dlimb was transected, and a segment of the medial
meniscus detached and excised by using a surgical
method [24] that we have established in our laboratory
[25]. It should be noted that this model of injury,
termed MLI, leads to posttraumatic OA that is detect-
able by 4 weeks after injury and progresses over a 4-
month period, similar to that seen in the DMM model
of posttraumatic OA [26]. The contralateral limb was
sham-operated and represented the experimental con-
t r o l .P r e -a n dp o s t s u r g e r ym i c ew e r ep r o v i d e da n a l g e s i a
(intraperitoneal (IP) injection of 0.5 mg/kg buprenor-
phine) every 12 hours for 72 hours. Before killing mice
at monthly intervals, the mice were fasted overnight,
weighed, and tail-vein blood samples were taken for
blood glucose measurements by using One Touch glu-
cose meters (Lifescan, Inc., Milpitas, CA). Hemoglobin
A1c measurements were made on tail-vein blood sam-
ples by using a Bayer DCA 2000 HgbA1C analyzer
(Deerfield, IL). The assay is based on monoclonal anti-
body detection of the glycated amino terminus of the b-
chain of human hemoglobin. The University Committee
on Animal Resources approved all protocols.
Tissue harvest and histologic analysis of OA progression
After establishment of deep anesthesia by using IP injec-
tion of 60 mg/kg ketamine and 4 mg/kg xylazine, mice
were killed via cardiac perfusion by using 10 ml of phos-
phate-buffered saline followed by 10% neutral buffered
formalin. Isolated knee joints were fixed for 3 days in
10% neutral buffered formalin at 23°C. Samples were
decalcified for 2 weeks in 10% wt/vol EDTA and
embedded in paraffin. Three-micrometer-thick sagittal
sections from the medial joint compartment of the right
knee were cut on a microtome and mounted on posi-
tively charged slides, baked at 60°C for 30 minutes,
deparaffinized in xylene, and rehydrated in decreasing
concentrations of ethanol.
Mouse knee-joint sections were stained with both
Safranin O-fast green and Alcian blue-hematoxylin to
allow visualization of cartilage tissue. Semiquantitative
histopathologic grading of Alcian blue-stained knee-joint
cartilage was performed on sagittal sections by using a
murine scoring system established by the OARSI histo-
pathology initiative [27], in which 0 = normal cartilage,
0.5 = loss of proteoglycan stain without cartilage
damage, 1 = mild superficial fibrillation, 2 = fibrillation
and/or clefting extending below the superficial zone, 3 =
mild (< 25%) loss of cartilage, 4 = moderate (25% to
50%) loss of cartilage, 5 = severe (50% to 75%) loss of
noncalcified cartilage, and 6 = eburnation with > 75%
loss of cartilage.
Quantification of cartilage morphologic features
After histologic grading, Alcian blue-stained sagittal sec-
tions were evaluated for cartilage area and thickness by
using OsteoMeasure software (OsteoMetrics, Decatur,
GA), as previously described [28]. Articular cartilage
was defined as the area from the joint surface to the
junction of the deep zone of the cartilage with the sub-
chondral bone, including the entire surface from the
anterior to the posterior edges of both the tibia and the
femur. Cartilage area was quantified in each section by
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we previously described [25]. Similarly, tibial cartilage
thickness was analyzed at the center of the tibial plateau.
Osteophytes were positively identified by using the fol-
lowing criteria: the osteophyte (a) protruded into the
joint space, (b) contained hypertrophic chondrocytes,
and (c) displayed evidence of calcification. Histologic
assessment of osteophytes was performed on each slide
by using a digital projection at ×100 magnification. The
largest cross-sectional dimension of the osteophyte was
measured, as was the perpendicular dimension. These
two determinations were averaged. Where multiple
osteophytes were detected, the mean of the average
osteophyte diameters was recorded. All three parameters
(thickness, area, osteophyte size) were determined and
averaged among all sections. Each diet group contained
five to eight mice, with three sections from each joint
being analyzed in the histologic grading and histomor-
phometric analyses.
Micro-computed tomography (micro-CT) evaluation of
mouse knee joints
Before histologic processing, knee joints were evaluated
with micro-CT by using a Scanco vivaCT 40 scanner
with 55-kVp source (Scanco USA, Inc., Wayne, PA).
Joints were scanned at a resolution of 12 μm, with a
slice increment of 10 μm. Images from each group were
reconstructed at identical thresholds to allow 3-dimen-
sional structural rendering of each joint. Analysis of
bone volume was performed on selected regions
between the femoral and tibial growth plates.
Statistical analysis
Results are expressed as mean values ± SEM. Statistical
analysis was performed by using StatView 5 software
(SAS Institute, Cary, NC). Data were tested for normal-
ity by using the Kolmogorov-Smirnov test (with Dallal-
Wilkinson-Lilliefor P value). Experimental means were
compared by using ANOVA; sample means from three
or more groups were compared, and the Fisher pro-
tected least significant differences test was used for
comparisons between pairs of groups. A calculated P
value of less than 0.05 was considered significant when
comparing between-group differences.
Results
Five-week-old C57BL/6 mice were placed on either an
HF diet representing 60% of total dietary kcal or an LF
(lean) diet with 10% of kilocalories derived from fat. The
HF diet has been shown to cause hyperglycemia and
insulin resistance in this strain of mice [29]. After 8
weeks, mice on the HF diet weighed 29% more than
those on the lean diet (30.9 ± 0.9 g versus 23.9 ± 0.6 g;
P < 0.0001; Figure 1a). Fasting blood glucose levels were
in the diabetic range only for the HF group (182.3 ±
1 0 . 5m g / d l ;F i g u r e1 B ) ,c o n f i rming a dysmetabolic state
associated with the HF diet.
Progression to severe OA is typically observed within
5 months by using the meniscal-ligamentous injury
(MLI) technique [25]. With the objective to determine
whether the HF diet with its associated type 2 diabetic
phenotype accelerates OA progression, mice from each
dietary group (n = 4 to 9) were killed at monthly inter-
vals out to 4 months after MLI surgery. Both groups
gained weight over this 4-month period, with the HF
group becoming markedly obese, with a peak weight of
45.9 ± 2.1 g compared with only 29.9 ± 1.8 g (P <
0.0001) for the lean group (Figure 1a). As expected, the
HF group was diabetic (fasting blood glucose greater
than 125 mg/dl), with peak levels of 288.8 ± 21.4 mg/dl
at 4 months (Figure 1b). Histologic analysis of the
articular cartilage at the 4-month time point revealed
increased fibrillation, clefting, and decreased proteogly-
can staining in response to MLI. These changes were
more pronounced in the HF group (P < 0.01; Figure 2a)
with major loss of cartilage. In some cases, this loss pro-
gressed nearly to the subchondral bone. No significant
cartilage loss was observed in sham-operated knees of
either HF or lean groups, with only occasional superfi-
cial zone fibrillation.
A progressive worsening of OA from 2 to 4 months
was demonstrated in both diet groups, with the score
for OA severity being significantly higher for the HF
group at each of these time points (Figure 2b). Data for
lean mice at month 1 indicate an unexpectedly advanced
stage of OA for that time point. The explanation for this
aberrant data point is not clear. With the OARSI score,
the HF group on average had 25% to 50% loss of articu-
lar cartilage at 2 months (score of 4), whereas the lean
group had less than 25% loss of articular cartilage at
this same time point (score of 3; P < 0.01). As expected,
the sham controls had scores of 1 or less, representing
only occasional superficial zone fibrillation, even at 4
months (data not shown).
Histomorphometric analysis of the articular cartilage
in the lean and HF groups over the 4-month time
course confirmed the accelerated loss of articular carti-
lage in the HF diet group. Articular cartilage thickness
on the tibial plateau progressively decreased in both
groups but was approximately 40% to 50% thinner in
the HF group between 2 and 4 months after MLI (Fig-
ure 2c). Similarly, total articular cartilage area, repre-
senting the combined cartilage areas of the femur and
tibia, decreased progressively with the most marked dif-
ference between lean and HF diets being observed at
the 4-month time point (Figure 2d). At this time point,
cartilage area in the HF group had decreased by an
additional 35% relative to lean controls (P < 0.01).
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l a t e rt i m ep o i n t sw e r em a r k e d l yo b e s ei nc o n s e q u e n c e
of a 6-month diet protocol that included 2 months of
the HF diet before the initiation of OA with MLI. To
determine whether this marked increase in body weight
was primarily responsible for the accelerated progression
of OA with HF feeding, two HF diet protocols were
compared. One group of mice (n =6 )w a sf e da nH F
Figure 1 High-fat diet promotes weight gain and hyperglycemia. Five-week-old male C57BL/6 mice were placed on either a high-fat (60%
kcal) or low-fat (10% kcal) diet for 2 months before meniscal-ligamentous injury (MLI). Body weight (a) and blood glucose levels (b) were
determined at monthly intervals after MLI. *P < 0.05; **P < 0.01; n = 5 to 9 mice at each time point.
Figure 2 Osteoarthritic changes were more pronounced in high-fat (HF) diet-treated mice. (a) Histologic sections of injured and sham joints
at 1-, 2-, 3-, and 4-month time points after meniscal-ligamentous injury (MLI) were stained with Alcian blue. Representative sections from the 4-
month time point are shown. Magnification, ×100. (b) Slides were graded for OA severity by using the OARSI histopathology initiative scoring
method for mice. The slides were also analyzed with histomorphometry for tibial cartilage thickness (c) and total articular cartilage area (tibia +
femur, d). All histomorphometry data were normalized to sham-operated joint-cartilage thickness and area, respectively, from lean mice. All results
are expressed as the mean ± SEM from at least five mice with three slides per mouse. *P < 0.05; **P < 0.01; n = 4 to 9 mice at each time point.
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initiation of OA. In a second group (n = 8), an HF diet
was begun only at the initiation of OA. As a result of
beginning the HF diet at the time of MLI, this group of
mice demonstrated only a modest increase in body
weight relative to the lean diet controls (n =7 )( F i g u r e
3a). This contrasts with the long-term HF diet group,
which again attained a marked obese body weight that
was 80% above that of lean mouse controls. Despite the
modest weight gain, the short-term HF group displayed
metabolic dysfunction, as indicated by fasting hypergly-
cemia at 1-, 2-, and 3-month time points, although
levels were less than those of the long-term HF group.
Values at 3 months are shown (Figure 3b). An addi-
tional marker for a dysmetabolic state, hemoglobin A1c,
a measure of average blood glucose levels over the pre-
ceding 3-month period [30], was nearly equally elevated
in the two HF groups (Figure 3c). Note that the absolute
hemoglobin A1c values were less than those of humans,
for whom this immunoassay-based test is designed.
These results indicate that the short-term HF diet pro-
duced metabolic dysfunction without requiring marked
obesity or the extended 3-month period on the HF diet
before the MLI surgery.
Histologic analysis of the progression of OA at 3
months after MLI confirmed that a long-term HF diet
was again associated with accelerated OA progression,
with major loss of cartilage relative to the lean controls.
In some cases, this loss progressed nearly to the sub-
chondral bone. Importantly, the short-term HF diet
group had an equally accelerated progression of OA
when compared with the long-term HF group (Figure
4a). No significant cartilage loss was observed in sham-
operated knees of either HF or lean groups, with only
occasional superficial zone fibrillation. These observa-
tions were confirmed by comparably higher
Figure 3 Differing weight gain but similar hyperglycemia in short- and long-term high-fat (HF) diets. Five-week-old male C57BL/6 mice
were given either a high-fat (60% kcal) or low-fat (10% kcal) diet for 3 months before meniscal-ligamentous injury (MLI). After MLI, half of the
lean group was switched to the HF diet. The three groups were maintained on diets for an additional 3 months. (a) Body weight was measured
monthly after the MLI procedure. (b) Blood glucose and (c) hemoglobin A1c levels were determined at the 3-month end point. Data points
represent mean ± SEM of at least six mice. *P < 0.05; **P < 0.01. n = 6 to 8 mice in each group.
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lean controls, as assessed by the OARSI scoring method
(P < 0.05; Figure 4b). It should be noted that the accel-
erated cartilage degeneration occurred in the short-term
HF group despite the absence of marked obesity. In
agreement with the OARSI scoring and supporting the
idea that marked obesity is not required for acceleration
of cartilage degeneration in mice fed an HF diet, tibial
plateau articular cartilage thicknesses were 25% to 50%
lower in the two HF groups compared with the lean
group (Figure 4c). Cartilage-area determination sup-
ported the thickness data by demonstrating similar
trends toward decreased area in both HF diet groups
relative to mice fed the lean diet (data not shown).
These results indicate that accelerated progression of
OA in mice on an HF diet is associated with a diabetic
metabolic phenotype, does not correlate with degree of
weight gain, and does not require prolonged exposure
to the HF diet.
Quantitative micro-CT analysis of knee joints at the 3-
month time point showed increased bone volume in the
MLI knees relative to sham-treated controls, consistent
with OA-like subchondral sclerosis and joint/periarticu-
lar mineralization. Only differences in the HF-diet
Figure 4 OA progression after meniscal-ligamentous injury MLI is comparable in mice on either short- or long-term HF diets. Injured
and sham joints at 3 months after MLI were harvested from the lean, short-term HF, and long-term HF groups. (a) Histologic slides were stained
with Alcian blue and (b) scored for OA severity by using the OARSI histopathology initiative scoring method for mice. The slides were also
analyzed with histomorphometry for tibial cartilage thickness, with the data normalized to the cartilage thickness determined in sham-operated
joints from lean mice (c). Results are expressed as the mean ± SEM from at least six mice with three slides per mouse. *P < 0.05; **P < 0.01. n =
6 to 8 mice in each group.
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Figure 5a).
Regarding enhanced joint and periarticular mineraliza-
tion specifically, 3-dimensional reconstructions of the
raw micro-CT data revealed a more progressive menis-
cal calcification and a suggestion of increased presence
of osteophytes in both high-HF groups relative to the
lean diet controls (Figure 5b). To investigate the possibi-
lity that HF diets promote the formation of osteophytes,
all histologic slides were evaluated for the presence and
size of osteophytes on the tibial surface. The blinded
analysis revealed osteophytes in essentially all MLI-
injured knees from all diet groups (Figure 6a). Impor-
tantly, not only was the size of the osteophytes greater
in both HF-diet groups (P < 0.01), but they also were of
comparable size in the short-term and long-term HF
groups (Figure 6b). Interestingly, 30% of sham knees
from HF-diet mice contained small osteophytes (Figure
6c), and another 20% showed early changes suggestive
of osteophytes. This was distinct from sham knees from
the lean mice, which did not display osteophytes, with
early changes evident only in less than 20% of knees
(Figure 6d). As with progression of cartilage
degeneration and loss, more-aggressive osteophyte for-
mation in MLI-injured knees from HF-diet mice is asso-
ciated with a diabetic metabolic phenotype but does not
correlate with degree of weight gain.
Discussion
The results of this study demonstrate that consumption
of a high-fat diet that leads to weight gain and diabetes
will accelerate the progression of OA that is initiated by
induction of a meniscal ligamentous injury. This effect
on OA does not correlate, however, with degree of
increase in body mass or exposure to a high-fat diet
before injury. Our study draws different conclusions
from the early work of Silberberg and Silberberg [31,32]
who established a link between high-fat diets and OA in
rodent models more than 50 years ago. In their pioneer-
ing work, they documented an increased incidence of
OA in aged mice on an HF diet with age end points of
12 to 24 months [33]. Interestingly, a conclusion drawn
from their data was that the incidence but not the rate
of progression of OA was affected by the HF diet [9]. In
our current study, we clearly establish that HF diets can
accelerate the progression of OA after a defined OA
initiation in a diarthrodial joint. Perhaps the variable
time of spontaneous initiation, the long timeline of OA
progression in the absence of a severe initiating injury,
and the absence of quantitative end points may have
contributed to the inability of Silberberg and Silberberg
to detect changes in rate of progression in their studies.
Alternatively, the effects of the HF diet on mechanisms
of OA initiation and progression in aging versus acute
injury may be different.
The relative contributions to OA of biomechanical
factors resulting from increased body mass versus meta-
bolic dysfunction in the obese and type 2 diabetic popu-
lation have not been resolved. In humans, a strong
correlation has been shown between elevated body mass
index (BMI) and OA [21-23]. Biomechanical factors
related to this increased body mass have been argued to
make critical contributions to OA of the knee [34,35].
As for metabolic factors, correlations exist between dia-
betic parameters (hyperglycemia, hyperinsulinemia) and
OA [36-39]. Another strong argument for systemic
metabolic factors contributing to OA in the obese and
diabetic population comes from the increased incidence
of OA in the hand, a site not susceptible to the biome-
chanical overload present in the weight-bearing joints of
an obese individual [37,38]. Logically, detrimental effects
of body mass on OA would be a function of both mag-
nitude of body-mass increase and length of exposure to
this condition after initiation of OA. Our short-term HF
diet group weighed the same as lean controls at the
time of injury and gained approximately 6 g over the
following 3-month period. In contrast, the long-term
Figure 5 Micro-CT analysis of knee joints after meniscal-
ligamentous injury (MLI) as a function of diet. (a) Knee-bone
volumes of MLI and sham-treated limbs at 3 months in HF, Lean to
HF, and Lean diet groups were analyzed with micro-CT. (b) Three-
dimensional reconstructions of knee joints were used to visualize
calcification of meniscus and osteophyte formation. Gray arrows,
ossification of meniscus; white arrows, osteophyte-like structures.
Representative 3D images are presented. Bone volume data
represent the mean ± SEM of at least five mice. **P < 0.01. n =6t o
8 mice in each group.
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trols at the time of knee injury and increased the differ-
ential to more than 20 g by 3 months. Despite this
obvious difference in duration and degree of exposure
to increased body mass, the two diet groups had com-
parable acceleration of OA progression. From our
results, we conclude that weight gain does not correlate
with progression of OA in our HF-diet mouse model.
Silberberg and Silberberg [40] came to a similar conclu-
sion that increased body weight in response to HF diets
does not correlate with the incidence of joint disease in
mice. Recently, Griffin et al. [41] reported the effect of
HF diet-induced obesity on spontaneous OA of aging in
female mice at 54 weeks of age and concluded that
weight gain and loss of Safranin-O cartilage staining or
OA severity score, but not cartilage degeneration, were
correlated. Their histologic data suggested a modest OA
progression with little loss of cartilage. Perhaps the early
stages of OA initiation and progression are more
strongly influenced by body mass. As cartilage
degeneration becomes more severe, as in our MLI
model, a high-fat diet continues to accelerate progres-
sion, and in this phase of the disease, the associated
metabolic dysfunction becomes more important.
Silberberg and co-workers [42] did not investigate the
metabolic dysfunction in their mouse models as a result
of HF diets, but they did observe that the C57BL/6
strain but not the DBA strain was susceptible to
increased OA of aging when on HF diets, despite weight
gain in both strains. Sokoloff et al. [43,44] also observed
that OA in the DBA strain was not altered by diet,
despite weight gain. Recently, Griffin et al. [45] reported
that markedly obese leptin-deficient mice do not have
an increased incidence of OA. These observations pro-
vide further evidence that factors other than increased
body mass are critical to the changes in OA in C57BL/6
mice. Interestingly, C57BL/6 mice are well known for
their susceptibility to diabetic changes (hyperinsuline-
mia, hyperglycemia) when placed on HF diets, whereas
DBA mice are resistant to these metabolic changes
Figure 6 Osteophyte analysis of knee joints after meniscal-ligamentous injury (MLI) as a function of diet. (a) A representative osteophyte
in a histologic section from an MLI-treated knee of an HF mouse is shown (boxed area). (b) Average osteophyte diameters on the tibial surface
were measured by using digitally projected images of the histologic slides. Results are expressed as the mean ± SEM from at least six mice, with
three slides per mouse. A representative osteophyte (boxed area) in a histologic section from a sham-operated knee of an HF mouse (c) and a
comparable location in an unaffected lean diet control (d) are shown. ×100 magnification. **P < 0.01. n = 6 to 8 mice in each group.
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lished, these observations show an association between
development of a diabetic phenotype and accelerated
progression of OA in the C57BL/6 mouse model.
In the mouse, metabolic changes in response to HF
diets appear to be important in mediating osteoarthritic
pathogenesis. Saturated fat diets derived from animal fat
(lard) are most effective in mediating OA changes
[31,44]. They are also more effective than dietary sugar
in generating obesity and diabetes in experimental mice
[47]. N-3 polyunsaturated fat (PUFA), such as linolenic
acid, decreases the detrimental effects of the lard diet
[48] and decrease expression and activity of proteogly-
can-degrading enzymes and expression of inflammatory
cytokines in articular chondrocyte cultures [49,50]. As a
potential mechanism of action, the n-3 or omega-3
PUFAs that are found in fish oils have been shown to
have anti-inflammatory effects with multiple mechan-
isms of action being proposed [51]. Importantly, one
PUFA, eicosapentaenoic acid, has recently been shown
to prevent and reverse insulin resistance in mice fed an
HF diet [52]. The mechanism of this latter effect has
been proposed to be suppression of adipose tissue
inflammation [52]. These results suggest that HF diets
mediate their effects on both OA and the diabetic phe-
notype, at least in part through inflammatory effects.
In relation to OA, the observation that obesity is a
proinflammatory state may have critical implications for
explaining both the increase dp r o g r e s s i o no fO Ai no u r
mouse model of obesity/type 2 diabetes and the epide-
miologic data linking obesity to OA. The proinflamma-
tory state of obesity may synergize with other OA-
promoting pathways to accelerate the progression of the
cartilage destruction. Thus, our laboratory is currently
investigating the contribution of systemic inflammation
to OA progression in obesity as a step toward elucidat-
ing novel candidate mechanisms that underlie the dele-
terious effect of the HF diet on the degenerative process.
Conclusions
The results of this study indicate that an HF diet acceler-
ates progression of OA in the C57BL/6 mouse diabetic
model after a meniscal ligamentous injury, as assessed by
both cartilage degeneration and osteophyte production.
Degree of weight gain does not correlate with these
changes, and prior exposure to the HF diet is not necessary
for these effects. This suggests that metabolic dysregulation
in type 2 diabetes is a comorbid factor in the progression
of osteoarthritis, and its effect is in addition to that of obe-
sity-related increased weight bearing in afflicted joints.
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